Mariko_Sato_3.jpg

Mariko Sato, M.D., Ph.D.

Radiation Oncologist
Associate Specialist, Southern TOHOKU BNCT Research Center

  • Present Title & Affiliation

    • Associate Specialist, Southern TOHOKU BNCT Research Center
    • Visiting Research Fellow, Hirosaki University Graduate School of Medicine, Japan

  • Education

    • 2009 M.D.

      Hirosaki University School of Medicine, Japan

    • 2009

      Japanese Medical License issued by the Ministry of Health, Labour and Welfare, Japan

    • 2015
      Hirosaki University Graduate School of Medicine, Japan

  • Certifications

    • Board-certified Radiologist by Japan Radiological Society (JRS)
    • Board-certified Radiation Oncologist by Japanese Society for Radiation Oncology (JASTRO)
    • Board-certified General Clinical Oncologist by Japanese Board of Cancer Therapy (JBCT)

  • Professional Experience

    • 2009

      Resident, Mutsu General Hospital, Japan

    • 2011

      Clinical Fellow, Dept. of Radiology and Radiation Oncology, Hirosaki University Hospital, Japan

    • 2015

      Lecturer, Dept. of Radiation Oncology, Hirosaki University Hospital, Japan

    • 2020-present

      Associate Specialist, Southern TOHOKU BNCT Research Center

  • Skill Highlights

    • Boron Neutron Capture Therapy (BNCT)
    • Radiation oncology
    • Radiation biology     

  • Professional Memberships

    • 2011-present

      Member, Japan Radiological Society (JRS)

    • Member, Japanese Society for Radiation Oncology (JASTRO)
    • 2020-present

      Member, Japanese Society of Neutron Capture Therapy (JSNCT)

  • Honers & Awards

    • 2019

      Best Presentation Award at 140th Northern Japan Congress of Japan Radiological Society (JRS)

    • Best Presentation Award at 16th Annual Meeting of Japanese Society of Neutron Capture Therapy (JSNCT)

  • Selected Publications

    • M. Sato, K. Hirose, M. Aoki, Y. Hatayama, H. Kawaguchi, H. Akimoto, Y. Narita, Y. Takai. How Can We Overcome Hypoxia- and Radiation-Induced EMT? - Contribution of Blockade on HIF-1 and JNK Phospholyration With LW6. International Journal of Radiation Oncology* Biology* Physics (56th ASTRO Annual Meeting). 2014, 90(1S): S771
    • M. Sato, K. Hirose, I. Kashiwakura, M. Aoki, H. Kawaguchi, Y. Hatayama, H. Akimoto, Y. Narita, Y. Takai. LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells. Molecular Medicine Reports 2015, 12:3462-3468
    • Aoki M, Sato M, Hirose K, Akimoto H, Kawaguchi H, Hatayama Y, Ono S, Takai Y. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: Impact of maximum dose and fraction size. Radiat Oncol 2015, 10(1):99
    • Hirose K, Sato M, Hatayama Y, Kawaguchi H, Komai F, Sohma M, Obara H, Suzuki M, Tanaka M, Fujioka I, Ichise K, Takai Y, Aoki M. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis. Radiat Oncol. 2018 Jun 7;13(1):106.
Back
Printer Friendly